Prelude Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$250K Buy
2024
Q3
Sell
2024
Q2
$700K Buy
2024
Q1
$544K Sell
2023
Q4
$694K Buy
2023
Q3
$295K Buy
2023
Q2
$310K Buy
2019
Q3
Hold
2019
Q2
Hold
2019
Q1
Hold
2018
Q4
Hold
2018
Q3
Sell
2018
Q2
$7K Buy